Organism name | Anthemis aciphylla BOISS.var.discoidea BOISS |
---|---|
Genus | Anthemis |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Anthemis |
---|---|
Linked NCBI taxonomy ID | 99027 |
Linked level | genus |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00030958
![]() |
Pentacosane
|
No. 115 |
![]() |
|||||
C00030471
![]() |
Heptacosane
|
No. 115 |
![]() |
|||||
C00001260
![]() |
Nonacosane
|
CHEMBL428955
|
C047577
|
No. 115 |
![]() |
|||
C00030479
![]() |
Hexadecanoic acid
/ n-Hexadecanoic acid |
CHEMBL82293
|
D019308
|
16 / 8 / 8 | 35 / 1 | No. 184 | No. 68 |
![]() |
C00003161
![]() |
Ledol
/ (+)-Ledol |
CHEMBL2171207
|
1 / 2 / 3 | No. 197 | No. 38 |
![]() |
||
C00020065
![]() |
alpha-Cadinol
/ (-)-alpha-Cadinol |
CHEMBL486795
|
No. 205 | No. 38 |
![]() |
|||
C00030345
![]() |
gamma-Cadinene
|
C054278
|
No. 283 | No. 39 |
![]() |
|||
C00029546
![]() |
Varamol 106
/ 4-Vinyl guaiacol |
C014245
|
No. 310 | No. 6 |
![]() |
|||
C00021884
![]() |
beta-Bourbonene
/ (E)-beta-Bourbonene |
No. 333 | No. 38 |
![]() |
||||
C00003118
![]() |
Copaene
/ alpha-Copaene / (-)-alpha-Copaene |
No. 333 | No. 38 |
![]() |
||||
C00012813
![]() |
Kongol
/ Selin-11-en-4alpha-ol / 5alpha,7alphaH-Eudesm-11(13)en-4alpha-ol / [1R-(1alpha,4abeta,7beta,8aalpha)]-decahydro-1,4a-dimethyl-7-(1-methylethenyl)-1-naphthalenol |
CHEMBL481844
CHEMBL505457 |
No. 398 | No. 38 |
![]() |
|||
C00029350
![]() |
Z-beta-Farnesene
/ (Z)-beta-Farnesene / beta-cis-Farnesene / cis-beta-Farnesene |
No. 404 | No. 38 |
![]() |
||||
C00011617
![]() |
AR-Curcumene
/ (R)-(-)-alpha-Curcumene |
CHEMBL469717
|
No. 456 | No. 38 |
![]() |
|||
C00030803
![]() |
Myrtenal
|
C061545
|
No. 476 | No. 35 |
![]() |
|||
C00000816
![]() |
beta-Pinene
|
CHEMBL501351
|
C010789
|
No. 476 | No. 35 |
![]() |
||
C00000863
![]() |
R-(+)-trans-Verbenol
|
No. 476 | No. 35 |
![]() |
||||
C00000829
![]() |
trans-Pinocarveol
|
No. 476 | No. 35 |
![]() |
||||
C00029977
![]() |
cis-Verbenol
|
No. 476 | No. 35 |
![]() |
||||
C00000805
![]() |
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
![]() |
C00012483
![]() |
Betula pubescens
/ Caryophyllene oxide / trans-Caryophyllene oxide / beta-Caryophyllene epoxide / (-)-Epoxydihydrocaryophyllene / 6,7-Epoxy-3(15)-caryophyllene / (-)-beta-Caryophyllene epoxide / 4beta,5alpha-Epoxycaryophyllene / Caryophyllene 4beta,5alpha-epoxide |
CHEMBL399036
CHEMBL508894 CHEMBL479134 CHEMBL1513806 CHEMBL1553274 |
3 / 1 / 3 | No. 500 |
![]() |
|||
C00030959
![]() |
Pentadecanal
|
C003061
|
No. 599 |
![]() |
||||
C00032309
![]() |
Tetradecanol
/ 1-Tetradecanol |
CHEMBL24022
|
C020940
|
1 / 0 / 0 | No. 599 |
![]() |
||
C00030480
![]() |
Hexahydrofarnesyl acetone
/ 6,10,14-Trimethyl-2-pentadecanone |
C014584
|
No. 641 | No. 38 |
![]() |
|||
C00003028
![]() |
Borneol
/ (+/-)-Borneol |
CHEMBL296404
CHEMBL486208 CHEMBL1097205 CHEMBL1968981 |
8 / 5 / 1 | No. 649 | No. 35 |
![]() |
||
C00012425
![]() |
Bicyclogermacren
/ Bicyclogermacrene / (+)-Bicyclogermacrene |
CHEMBL509566
|
No. 699 | No. 38 |
![]() |
|||
C00007242
![]() |
beta-Bisabolene
/ l-beta-Bisabolene / (-)-beta-Bisabolene |
CHEMBL444389
CHEMBL1077088 CHEMBL2001434 |
No. 701 | No. 38 |
![]() |
|||
C00032409
![]() |
Tricosane
|
No. 732 |
![]() |
|||||
C00029422
![]() |
1-Octadecanol
/ Octadecan-1-ol |
CHEMBL24640
|
C009316
|
3 / 11 / 10 | No. 732 |
![]() |
||
C00030154
![]() |
Okimelanolure
/ Dodecyl acetate / n-Dodecyl acetate |
C044215
|
No. 793 |
![]() |
||||
C00030100
![]() |
Decanol
/ 1-Decanol / n-Decanol |
CHEMBL25363
|
C029383
|
1 / 0 / 0 | 1 / 0 | No. 877 |
![]() |
|
C00003047
![]() |
Linalool
/ (R)-linalool / (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol |
CHEMBL25306
CHEMBL235672 |
C018584
|
6 / 8 / 2 | 35 / 4 | No. 958 | No. 34 |
![]() |
C00000155
![]() |
Thymol
|
CHEMBL29411
|
D013943
|
9 / 17 / 14 | 12 / 0 | No. 969 | No. 35 |
![]() |
C00000156
![]() |
Carvacrol
|
CHEMBL281202
|
C073316
|
10 / 6 / 1 | 4 / 2 | No. 969 | No. 35 |
![]() |
C00029674
![]() |
alpha-Terpineol
|
CHEMBL447597
CHEMBL449810 |
C016775
|
3 / 16 / 11 | No. 983 | No. 35 |
![]() |
|
C00001231
![]() |
Caprylic acid
/ Octanoic acid / n-Octanoic acid |
CHEMBL324846
|
C031492
|
10 / 14 / 13 | 2 / 1 | No. 1141 | No. 68 |
![]() |
C00001213
![]() |
Capric acid
/ Decanoic acid / n-Decanoic acid |
CHEMBL107498
|
C031071
|
8 / 11 / 6 | 4 / 0 | No. 1141 | No. 68 |
![]() |
C00001221
![]() |
Lauric acid
/ Docosanoic acid / n-Dodecanoic acid |
CHEMBL108766
|
C030358
|
19 / 25 / 14 | 11 / 0 | No. 1141 | No. 68 |
![]() |
C00001228
![]() |
Myristic acid
/ Tetradecanoic acid / n-Tetradecanoic acid |
CHEMBL111077
|
D019814
|
17 / 9 / 10 | 3 / 0 | No. 1141 | No. 68 |
![]() |
C00030829
![]() |
Pelargonic acid
/ n-Nonanoic acid |
CHEMBL108436
|
C008776
|
4 / 4 / 2 | 3 / 1 | No. 1141 | No. 68 |
![]() |
C00000154
![]() |
p-trans-Menth-2-en-1-ol
|
No. 1151 |
![]() |
|||||
C00029973
![]() |
cis-p-Menth-2-en-1-ol
|
No. 1151 |
![]() |
|||||
C00031258
![]() |
Sabinene
/ 4(10)-Thujene |
CHEMBL452687
|
C035127
|
No. 1343 | No. 35 |
![]() |
||
C00030347
![]() |
gamma-Dodecalactone
|
CHEMBL195215
CHEMBL1269378 |
1 / 0 / 0 | No. 1374 |
![]() |
|||
C00007636
![]() |
delta-Cadinene
|
CHEMBL445759
|
No. 1524 | No. 39 |
![]() |
|||
C00029971
![]() |
cis-Carveol
|
CHEMBL1385229
CHEMBL1907992 CHEMBL1908058 |
6 / 15 / 40 | No. 1555 | No. 35 |
![]() |
||
C00000814
![]() |
(-)-trans-Carveol
|
CHEMBL1385229
CHEMBL1907992 CHEMBL1908058 |
6 / 15 / 40 | No. 1555 | No. 35 |
![]() |
||
C00000149
![]() |
Spathulenol
|
CHEMBL518542
CHEMBL1774433 |
C013258
|
No. 1603 |
![]() |
|||
C00029335
![]() |
beta-Ocimene
/ E-beta-Ocimene / (E)-beta-Ocimene |
C443996
|
No. 1698 | No. 34 |
![]() |
|||
C00029351
![]() |
Z-beta-Ocimene
/ cis-beta-Ocimene / (Z)-beta-Ocimene |
No. 1698 | No. 34 |
![]() |
||||
C00001264
![]() |
Octanol
/ n-Octanol / 1-Octanol / Octan-1-ol |
CHEMBL26215
|
D020003
|
5 / 6 / 5 | 2 / 0 | No. 1749 |
![]() |
|
C00030830
![]() |
Nonanol
/ n-Nonanol |
CHEMBL24563
|
C014713
|
1 / 0 | No. 1749 |
![]() |
||
C00030346
![]() |
gamma-Curcumene
|
No. 1788 | No. 38 |
![]() |
||||
C00010872
![]() |
beta-Phellandrene
/ (+/-)-beta-Phellandrene |
CHEMBL444254
|
C058582
|
No. 1898 | No. 35 |
![]() |
||
C00030828
![]() |
Nonanal
/ n-Nonanal |
C008664
|
1 / 1 | No. 1993 |
![]() |
|||
C00030099
![]() |
Decanal
/ Capraldehyde |
C021170
|
2 / 0 | No. 1993 |
![]() |
|||
C00031273
![]() |
Salicylaldehyde
|
CHEMBL108925
|
C013243
|
2 / 4 / 2 | No. 2076 |
![]() |
||
C00030881
![]() |
Octyl 2-methylbutyrate
|
No. 2098 |
![]() |
|||||
C00029330
![]() |
(E)-2-Decenal
|
CHEMBL507518
|
No. 2140 |
![]() |
||||
C00029331
![]() |
(E)-2-Nonenal
/ trans-2-Nonenal |
CHEMBL450072
|
1 / 0 / 0 | No. 2140 |
![]() |
|||
C00029332
![]() |
(E)-2-Undecenal
/ trans-2-Undecenal |
CHEMBL451328
|
No. 2140 |
![]() |
||||
C00003040
![]() |
p-Cymene
|
CHEMBL442915
|
C007210
|
No. 2172 | No. 35 |
![]() |
||
C00029997
![]() |
(E,Z)-2,4-Decadienal
/ trans-2,cis-4-Decadienal |
CHEMBL443949
|
8 / 12 / 42 | No. 2201 |
![]() |
|||
C00029341
![]() |
(E,E)-2,4-Decadienal
/ 2-trans,4-trans-Decadienal |
CHEMBL443949
|
8 / 12 / 42 | No. 2201 |
![]() |
|||
C00029544
![]() |
4-Terpineol
/ Terpin-4-ol / Terpineol-4 / Terpinen-4-ol |
CHEMBL507795
|
C034019
|
1 / 3 / 0 | No. 2215 |
![]() |
||
C00003032
![]() |
Chrysanthenone
|
No. 2232 | No. 35 |
![]() |
||||
C00000853
![]() |
Myrcene
|
CHEMBL455491
|
C008574
|
3 / 3 / 3 | No. 2285 | No. 34 |
![]() |
|
C00003204
![]() |
l-Zingiberene
/ (-)-Zingiberene / alpha-Zingiberene |
CHEMBL479020
|
No. 2380 | No. 38 |
![]() |
|||
C00003060
![]() |
alpha-Terpinene
|
No. 2468 | No. 35 |
![]() |
||||
C00003061
![]() |
gamma-Terpinene
/ 1-Methyl-4-(1-methylethyl)-1,4-cyclohexadiene |
CHEMBL449693
|
C018669
|
No. 2468 | No. 35 |
![]() |
||
C00029336
![]() |
(E)-Geranyl acetone
/ trans-Geranylacetone |
No. 2572 |
![]() |
|||||
C00030525
![]() |
Isofaurinone
|
No. 2633 |
![]() |
|||||
C00011720
![]() |
Germacrene D
/ (-)-Germacrene D |
CHEMBL105432
CHEMBL1836650 |
No. 2639 | No. 38 |
![]() |
|||
C00029316
![]() |
(2E)-Octenal
/ (E)-2-Octenal / trans-Oct-2-en-1-al |
CHEMBL448058
|
No. 2883 |
![]() |
||||
C00030880
![]() |
Octanal
/ n-Octanal |
CHEMBL18407
|
C031639
|
2 / 0 | No. 3593 |
![]() |
||
C00000357
![]() |
Hexanal
|
CHEMBL280331
|
C010463
|
7 / 0 | No. 3593 |
![]() |
||
C00000861
![]() |
Terpinolene
|
CHEMBL454697
|
C027009
|
1 / 0 | No. 3725 |
![]() |
||
C00021428
![]() |
Mintketone
/ Salvial-4(14)-en-1-one |
No. 3830 |
![]() |
|||||
C00030376
![]() |
Geranyl isovalerate
|
No. 4019 |
![]() |
|||||
C00000136
![]() |
1,8-Cineole
|
CHEMBL485259
CHEMBL1397305 |
99 / 57 / 50 | No. 5413 | No. 35 |
![]() |
||
C00029345
![]() |
(Z)-3-Hexen-1-yl benzoate
|
No. 6091 |
![]() |
|||||
C00030882
![]() |
Octyl isovalerate
/ 2-Octyl 3-methyl butyrate |
No. 6522 |
![]() |
|||||
C00029667
![]() |
alpha-Campholene aldehyde
|
No. 6876 |
![]() |
|||||
C00031068
![]() |
p-Mentha-1,5-dien-8-ol
|
No. 7280 |
![]() |
|||||
C00030933
![]() |
p-Cymen-8-ol
|
No. 8611 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000155 C00000156 C00000814 C00001213 C00001221 C00003028 C00003047 C00029544 C00029674 C00029971 | 3 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000136 C00000805 C00000814 C00000853 C00001213 C00001221 C00001231 C00029341 C00029971 C00029997 | 3 / 2 |
O75496 | Geminin | Unclassified protein | C00000136 C00001213 C00001228 C00001231 C00029422 C00030479 C00030829 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000155 C00000156 C00000814 C00003028 C00003047 C00029674 C00029971 | 5 / 1 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000136 C00000853 C00001213 C00001231 C00001264 C00030479 | 0 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00000853 C00001221 C00001228 C00030100 C00030479 C00032309 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000156 C00001213 C00001221 C00001228 C00001231 C00003028 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00001213 C00001221 C00029341 C00029997 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000155 C00000156 C00000814 C00003028 C00029971 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000156 C00001213 C00001221 C00001228 C00001231 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001221 C00001231 C00001264 C00029341 C00029997 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000136 C00001221 C00001228 C00001264 C00003047 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000136 C00000155 C00001231 C00029422 C00029674 | 11 / 10 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000155 C00000156 C00003028 C00003047 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000814 C00029341 C00029971 C00029997 | 7 / 37 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001221 C00001264 C00003047 C00030829 | 3 / 1 |
P10275 | Androgen receptor | NR3C4 | C00000136 C00001221 C00030479 | 3 / 4 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000155 C00000156 C00003028 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000155 C00000156 C00003028 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000136 C00001221 C00030479 | 1 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001228 C00029341 C00029997 | 2 / 3 |
P10145 | Interleukin-8 | Secreted protein | C00001221 C00029341 C00029997 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000136 C00030347 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000136 C00000805 | 0 / 0 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00000155 C00000156 | 1 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00029341 C00029997 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001213 C00001221 | 5 / 3 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001228 C00030479 | 2 / 2 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000136 C00012483 | 1 / 1 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00000814 C00029971 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000136 C00012483 | 0 / 1 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001221 C00001228 | 0 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00029331 C00031273 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000136 C00001221 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00029341 C00029997 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000136 C00000155 | 0 / 3 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001228 C00030479 | 0 / 0 |
O60603 | Toll-like receptor 2 | Membrane receptor | C00001228 C00030479 | 1 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000136 C00000156 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001228 C00030829 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000136 C00012483 | 0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001264 | 3 / 3 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000136 | 1 / 8 |
P11387 | DNA topoisomerase 1 | Isomerase | C00030479 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000136 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000136 | 2 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000136 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000136 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000136 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000136 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000136 | 1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001228 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000136 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000136 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000136 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001228 | 2 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000136 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001228 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001228 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00030479 | 1 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001231 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000136 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000136 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000136 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000136 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000136 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000136 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000136 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000136 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000136 | 1 / 0 |
P12104 | Fatty acid-binding protein, intestinal | Other cytosolic protein | C00030479 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000136 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000136 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000136 | 1 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000136 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000136 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000136 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000136 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001221 | 7 / 3 |
Q9UGP5 | DNA polymerase lambda | Enzyme | C00001221 | 0 / 0 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00001231 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000136 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000136 | 1 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00030479 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000136 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000136 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000136 | 1 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00031273 | 4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000136 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000136 | 2 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00001221 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000136 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000136 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000136 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000136 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000136 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000136 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00030479 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00000136 | 0 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00003161 | 2 / 3 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000136 | 1 / 0 |
P05413 | Fatty acid-binding protein, heart | Other cytosolic protein | C00030479 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000136 | 2 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00030829 | 0 / 0 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00000136 | 0 / 0 |
Q01469 | Fatty acid-binding protein, epidermal | Other cytosolic protein | C00030479 | 0 / 0 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00003028 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000136 | 2 / 2 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000136 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000136 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000136 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000136 | 0 / 0 |
Q05193 | Dynamin-1 | Structural | C00001228 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000136 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000136 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000136 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000136 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000136 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000136 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000136 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000136 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00003047 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
P15090 | Fatty acid-binding protein, adipocyte | Other cytosolic protein | C00030479 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000136 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00029422 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000136 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000136 | 4 / 3 |
P08246 | Neutrophil elastase | S1A | C00000136 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000136 | 2 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000136 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000136 | 0 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00000136 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000136 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000136 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000136 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001221 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000136 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001228 | 1 / 1 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00001231 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000136 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001221
C00001228
C00001231
C00030479
C00030829 |
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00001213
C00001221
C00001231
C00001264
C00030829 |
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000357
C00030099
C00030828
C00030880
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001213
C00001221
C00001228
C00030479
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000861
C00003047
C00030479
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000155
C00000156
C00030479
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000357
C00003047
|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000155
C00000156
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00000357
C00003047
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000357
C00030880
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000155
C00030479
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001213
C00001221
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00000357
C00030099
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001221
C00030479
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000155
C00030479
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001221
C00030479
|
199974 | CYP4Z1, CYP4A20 | cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) |
C00001221
C00001228
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001264
C00030100
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00003047
C00030479
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00030479
|
1447 | CSN2, CASB | casein beta |
C00003047
|
1509 | CTSD, CLN10, CPSD | cathepsin D (EC:3.4.23.5) |
C00003047
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003047
|
1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00003047
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003047
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00003047
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00003047
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00003047
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00003047
|
3297 | HSF1, HSTF1 | heat shock transcription factor 1 |
C00003047
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00003047
|
3308 | HSPA4, APG-2, HS24/P52, HSPH2, RY, hsp70, hsp70RY | heat shock 70kDa protein 4 |
C00003047
|
3316 | HSPB2, HSP27, Hs.78846, LOH11CR1K, MKBP | heat shock 27kDa protein 2 |
C00003047
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00003047
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00003047
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003047
|
8850 | KAT2B, CAF, P, P/CAF, PCAF | K(lysine) acetyltransferase 2B (EC:2.3.1.48) |
C00003047
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00003047
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00003047
|
4852 | NPY, PYY4 | neuropeptide Y |
C00003047
|
100124292 |
C00003047
|
||
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00003047
|
7471 | WNT1, BMND16, INT1, OI15 | wingless-type MMTV integration site family, member 1 |
C00003047
|
26118 | WSB1, SWIP1, WSB-1 | WD repeat and SOCS box containing 1 |
C00003047
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003047
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001221
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001221
|
1579 | CYP4A11, CP4Y, CYP4A2, CYP4AII | cytochrome P450, family 4, subfamily A, polypeptide 11 (EC:1.14.15.3) |
C00001221
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003047
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00003047
|
64127 | NOD2, ACUG, BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, NOD2B, PSORAS1 | nucleotide-binding oligomerization domain containing 2 |
C00001221
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00003047
|
1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00003047
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00003047
|
9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 |
C00001213
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00030830
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00000156
|
501 | ALDH7A1, ATQ1, EPD, PDE | aldehyde dehydrogenase 7 family, member A1 (EC:1.2.1.3 1.2.1.8 1.2.1.31) |
C00000357
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000156
|
9131 | AIFM1, AIF, CMTX4, COWCK, COXPD6, PDCD8 | apoptosis-inducing factor, mitochondrion-associated, 1 |
C00000155
|
218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00000357
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00030829
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000155
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000155
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000155
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000155
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000155
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000155
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000155
|
9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00030479
|
1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00003047
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00030479
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00030479
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00030479
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00030479
|
3034 | HAL, HIS, HSTD | histidine ammonia-lyase (EC:4.3.1.3) |
C00030479
|
57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide |
C00030479
|
3481 | IGF2, C11orf43, IGF-II, PP9974 | insulin-like growth factor 2 (somatomedin A) |
C00030479
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00030479
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00030479
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00030479
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00030479
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00030479
|
4494 | MT1F, MT1 | metallothionein 1F |
C00030479
|
4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H |
C00030479
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00030479
|
4502 | MT2A, MT2 | metallothionein 2A |
C00030479
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00030479
|
3651 | PDX1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1 | pancreatic and duodenal homeobox 1 |
C00030479
|
29893 | PSMC3IP, GT198, HOP2, HUMGT198A, ODG3, TBPIP | PSMC3 interacting protein |
C00030479
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00030479
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00030479
|
23216 | TBC1D1, TBC, TBC1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
C00030479
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00030479
|
7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00030479
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#114550 | Hepatocellular carcinoma |
P08581
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#246300 | Leprosy, susceptibility to, 3; lprs3 |
O60603
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00344 | Leprosy |
O60603
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
P08581 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003877 | Dermatitis, Contact |
C00000805
|
D009336 | Necrosis |
C00030828
|
D011041 | Poisoning |
C00030829
|
D017453 | Dermatitis, Irritant |
C00003047
|
D006937 | Hypercholesterolemia |
C00003047
|
D007938 | Leukemia |
C00003047
|
D009369 | Neoplasms |
C00003047
|
D003128 | COMA |
C00001231
|
D003866 | Depressive Disorder |
C00000156
|
D010146 | Pain |
C00000156
|
D003072 | Cognition Disorders |
C00030479
|